期刊文献+

432例女性不孕患者抗精子抗体和抗子宫内膜抗体检测分析 被引量:1

Detection and analysis of antisperm antibody and antiendometrial antibody in 432 female infertile patients
原文传递
导出
摘要 目的:探讨抗精子抗体(AsAb)、抗子宫内膜抗体(EMAb)检测在女性不孕中的检测意义。方法:选取432例女性不孕患者为女性不孕组,88例正常孕妇为对照组,采用ELISA法对所有受试者血清检测AsAb总抗体、EMAb总抗体,同时与对照组作对比分析。结果:不孕组抗精子总抗体(AsAb)的阳性率为13.2%(57/432),对照组抗精子总抗体阳性率为4.6%(4/88),经统计学处理,两组差异有显著性(χ2=5.28,P<0.05);EMAb总抗体检测不孕组总阳性率为15.2%(66/432),对照组阳性率为6.8%(6/88),两组差异有显著性(χ2=4.39,P<0.05)。结论:AsAb、EMAb与女性不孕密切相关,高水平的AsAb、EMAb可能是女性不孕的一个重要因素;AsAb、EMAb检测有必要列为女性不孕检查的一项常规项目。 Objective : To explore the detection value of antisperm antibody (AsAb) and antiendometrial antibody (EmAb) in female infertile patients. Methods: 432 female infertile patients as infertility group,and 88 pregnant women as normal comparison group were involved, AsAb and EmAb in serum of both groups were determined by ELISA and the resuhs of two groups were compared and analyzed. Results: Positive rate of AsAb in female infertility group accounted for 13.2% (57/432), that of normal comparison group was 4.6% (4/88), the difference of two groups had significant difference by statistical analysis (X^2 = 5.28,P 〈 0.05 ). The positive rate of EmAb in female infertility group accounted for 15.2% (66/432), that of normal comparison group was 6.8% ( 6/88 ), and the difference of two groups was significant (X^2 =- 4.39, P 〈 0.05 ). Conclusion: Detection of AsAb and EmAb had close relation to female infertility, female infertility.
出处 《中国卫生检验杂志》 北大核心 2012年第8期1903-1904,共2页 Chinese Journal of Health Laboratory Technology
关键词 抗精子抗体 抗子宫内膜抗体 女性不孕 检测分析 Antisperm antibody (AsAb) Antiendometrial antibody (EmAb) Female infertility Detection
  • 相关文献

参考文献4

二级参考文献17

  • 1刘世平,黎慧娟.ELISA法检测不育症患者体内抗精子抗体,抗子宫内膜抗体[J].中国实验临床免疫学杂志,1995,7(6):43-45. 被引量:1
  • 2黄邱朝 刘琦 等.抗子宫内膜抗体ELISA检测法的建立与临床应用[J].中华医学检验杂志,1993,16(1):29-29.
  • 3世界卫生组织编 北京协和医院和国家计划生育委员会科学技术所译.不育夫妇标准检查与诊断手册[M].北京:中国协和医科大学出版社,1997.1-4.
  • 4Meek SC,Hodge DD,Musich JR,et al.Autoimmunity in infertile patients with endometrosis[J].Am J Obstet Gynecol,1988,158 (6 Pt 1):1365.
  • 5Naz RK.Modalities for treatment of antisperm antibody mediated infertility[J].novel perspectives AJRI,2004,51 (5):3 902-3 971.
  • 6Kanakas N,Mantzavinos T,Boufidou F,et al.Ureaplapsma urealyticum in semen:is there any effect on in vitro fertilization outcome?[J].Ferti Steril,1999,71 (3):523 -527.
  • 7Clark GN,Hgne RV,Plessis Y,et al.Spermantibodias and human in vitro fertilization[J].Fertil Steri1,1998,49(6):10 -18.
  • 8Bohring C,Krause W.The role of antisperm antibodies during fertilization and for immunological infertility[J].Chem Immunol Allergy,2005,88(1):15 -26.
  • 9Naz RK,Chauhan SC.Presence of antibodies to sperm YLP(12) synthetic peptide in sera and seminal plasma of immunoinfertile men[J].Mol Hum Reprod,2001,7(1):21 -26.
  • 10Rossato M,Foresta C.Antisperm antibodies in inflammatory bowel disease[J].Arch Intern Med,2004,164(20):2 283.

共引文献9

同被引文献13

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部